Hyperfine, Inc.
HYPRHealthcareNASDAQMedical Devices · Last scanned Sep 8, 2026
Scan Results
Daily timeframeHyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. At a $87.2M market cap, Hyperfine, Inc. ranks as a micro-cap company within healthcare. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Market Cap
$87.2M
Beta
1.41
P/E (TTM)
—
P/E (Fwd)
-2.57
EPS (TTM)
$-0.37
EPS (Fwd)
$-0.32
ROE
-97.0%
ROA
-38.8%
Cash
$43.5M
Total Debt
$13.4M
Free CF
-$17.2M
52W Change
-38.4%
Annual Financials
Cash vs Debt
Where HYPR stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, HYPR finished 33.06% below its 150-day moving average ($1.21) and 31.36% below its 200-day moving average ($1.18). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HYPR overbought or oversold?
At the September 3, 2026 close, HYPR's RSI(14) was 18.3, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $43.5M in cash and $13.4M in debt, HYPR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$17.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -97.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $6.8M (2022) to $13.6M (2025), reflecting a 99% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Hyperfine, Inc. and its sector.